Faculty

Institution

Unit

Venue

Ashley Holder

Associate Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Cancer Medicine

Division Of Internal Medicine

Department Of Dermatology

Department Of Head And Neck Surgery

Division Of Surgery

Department Of Infectious Diseases

Division Of Internal Medicine

Division Of Cancer Medicine

Department Of Melanoma Medical Oncology

Department Of Melanoma Oncology

Section Of Hepato-Pancreato-Biliary

Department Of Surgical Oncology

Division Of Surgery

Department Of Surgical Oncology

Department Of Surgical Oncology, Section Of Surgical Endocrinology, United States

The University of Texas MD Anderson Cancer Center

Ashley Holder is currently serving as a Breast Surgical Oncology Associate Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ashley Holder

The University of Texas MD Anderson Cancer Center

Associate Professor

You can click a keyword to filter the displayed items

oncology dermatology cancer research melanoma cancer care radiation oncology cancer immunotherapy surgical oncology skin cancer dermatological treatment cancer imaging cell biology oncogenes cellular therapy cancer biology pharmacology breast cancer cancer management cancer treatment vascular biology medicinal research cancer cells cell signaling outcomes research clinical research drug resistance leukemia enzyme inhibition molecular cell biology clinical evidence breast oncology tumor targeting lymphatic system dermatological surgery cancer disparities shorter survival breast cancer patients molecular physiology pharmacotherapy biological chemistry pharmacological research medical guideline cutaneous biology clinical guidance nucleic acid biomarkers inhibitory activity tumor heterogeneity early detection signaling pathways cell regulation genetic disorders drug targets mechanisms of action cell migration immune checkpoint inhibitors spatial omics nano-drug delivery therapeutic nanomaterials data quality health care disparities evidence-based practice cancer registration solid tumours useful biomarkers pi3-kinase/akt/mtor signaling pathway nccn guidelines nccn guidelines® insights nccn panel meets mouse model recurrent deletions congenital diaphragmatic hernia mtor inhibitors catalytic mtor inhibitors rapamycin resistance clinical response braf inhibitors surgery metastasis plastic surgery gynecologic oncology thoracic surgery oral pathology kidney cancer neuro-oncology anatomical pathology microsurgery gross anatomy ovarian cancer pathology molecular cancer gastrointestinal surgery tumor microenvironment jama oncology aesthetic surgery bladder cancer reconstructive microsurgery surgical education gynecologic cancers sarcoma surgical pathology lung cancer cancer letter tumor biology carcinogenesis thoracic oncology brain tumor research cancer discovery mesothelioma histopathology aesthetic plastic surgery

Notable Scholarly Works

Notable Federal Grants

Collaborators

CORRECTION: Real-World Outcomes for Patients With Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection. Annals of Surgical Oncology (2026)

radiation oncologynodal dissectioncancer immunotherapysurgical oncologymelanomadermatologycancer imagingdermatological surgerycancer careoncologyreal-world outcomes

Leveraging the Human Microbiome to Improve Immunotherapy Sensitivity. Surgical Oncology Clinics of North America (2026)

clinical microbiologyinfectious diseasesimmunologygut microbesimmune responsesimmunity (medicine)microbiome

Abstract Ct243: Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma. Cancer Research (2025)

oncogenesradiation oncologytumor biologyskin cancerdermatologyphase 2abstract ct243cancer researchcancer geneticsjama oncologycancer treatmentcancer letteroncology

Expanded Accrual and Analysis of Neoadjuvant Plus Adjuvant (Neo+Adj) Dabrafenib (D) + Trametinib (T) in Patients (Pts) With Resectable Stage (Stg) III/IV Melanoma. EJC Skin Cancer (2025)

radiation oncologycancer immunotherapyiii/iv melanomasurgical oncologymelanomadermatologyskin cancerresectable stagecancer treatmentcancer careoncology

Leadership in Action: Tales From the Trenches. Journal of Surgical Research (2025)

Brittany M DacierCary B AaronsKarl Y BilimoriaLesly A DossettByron FalerAdil H HaiderMelina KibbeAshley M HolderJoseph D Phillips

strategic studieseducational leadershipethical leadershiporganization studiesadministrative leadershipmanagementleadership development

Systemic Therapy for Melanoma. Surgical Oncology Clinics of North America (2025)

melanomadermatologydermatological treatmentsystemic therapysystemic treatmentoncology

1258 High Social Vulnerability is Associated With Decreased Richness and Variability in the Gut Microbiome and Decreased Survival in Melanoma and Sarcoma Patients Treated With Immune Checkpoint Blockade. Regular and Young Investigator Award Abstracts (2024)

Brittany C FieldsRaymond S TraweekRussell G WittAshish V DamaniaEmily Z KeungElise F Nassif HaddadCarrie R Daniel-MacDougallNadim J AjamiManoj ChelvanambiJennifer A WargoChristina L RolandAshley M Holder

immune checkpoint blockadehigh social vulnerabilityinfectious diseasesdecreased richnessvulnerabilitygut microbiomedysbiosissarcoma patientsmicrobiome

Aso Author Reflections: Synoptic Reporting for Melanoma Nodal Surveillance Ultrasonography. Annals of Surgical Oncology (2024)

Kelsey B. MontgomeryAshley M. HolderKristy K. Broman

microscopymedical ultrasoundsurgerymedical imagingsurgical oncologymelanomadermatologymedical image analysisradiologycancer imagingcancer researchaso author reflectionsultrasoundoncologybiomedical imaging

Aso Visual Abstract: Interdisciplinary Implementation of a Synoptic Reporting Template for Melanoma Nodal Surveillance Ultrasound. Annals of Surgical Oncology (2024)

Kelsey B. MontgomeryZoey N. DuncanAshley M. HolderConstantine M. BurganSamuel J. GalganoKristy K. Broman

interdisciplinary implementationsurgerysurgical oncologymelanomaultrasound

Defining Clinically Useful Biomarkers of Immune Checkpoint Inhibitors in Solid Tumours. Nature reviews. Cancer (2024)

Ashley M. HolderAikaterini DedeiliaKailan Sierra-DavidsonSonia CohenDavid LiuAparna ParikhGenevieve M. Boland

solid tumoursgliomasdermatologycarcinogenesispharmacologyvascular biologykidney cancerenzyme inhibitioninhibitory activitymedicinal researchprostate cancercellular therapymesotheliomaclinical evidenceurologyearly detectionleukemiauseful biomarkerstumor heterogeneitynucleic acid biomarkers

1
2
3
4
10 / page

Ashley Holder

Associate Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Breast Surgical Oncology

Division Of Cancer Medicine

Division Of Internal Medicine

Department Of Dermatology

Department Of Head And Neck Surgery

Division Of Surgery

Department Of Infectious Diseases

Division Of Internal Medicine

Division Of Cancer Medicine

Department Of Melanoma Medical Oncology

Department Of Melanoma Oncology

Section Of Hepato-Pancreato-Biliary

Department Of Surgical Oncology

Division Of Surgery

Department Of Surgical Oncology

Department Of Surgical Oncology, Section Of Surgical Endocrinology, United States

The University of Texas MD Anderson Cancer Center

Ashley Holder is currently serving as a Breast Surgical Oncology Associate Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ashley Holder

The University of Texas MD Anderson Cancer Center

Associate Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

CORRECTION: Real-World Outcomes for Patients With Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection. Annals of Surgical Oncology (2026)

radiation oncologynodal dissectioncancer immunotherapysurgical oncologymelanomadermatologycancer imagingdermatological surgerycancer careoncologyreal-world outcomes

Leveraging the Human Microbiome to Improve Immunotherapy Sensitivity. Surgical Oncology Clinics of North America (2026)

clinical microbiologyinfectious diseasesimmunologygut microbesimmune responsesimmunity (medicine)microbiome

Abstract Ct243: Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma. Cancer Research (2025)

oncogenesradiation oncologytumor biologyskin cancerdermatologyphase 2abstract ct243cancer researchcancer geneticsjama oncologycancer treatmentcancer letteroncology

Expanded Accrual and Analysis of Neoadjuvant Plus Adjuvant (Neo+Adj) Dabrafenib (D) + Trametinib (T) in Patients (Pts) With Resectable Stage (Stg) III/IV Melanoma. EJC Skin Cancer (2025)

radiation oncologycancer immunotherapyiii/iv melanomasurgical oncologymelanomadermatologyskin cancerresectable stagecancer treatmentcancer careoncology

Leadership in Action: Tales From the Trenches. Journal of Surgical Research (2025)

Brittany M DacierCary B AaronsKarl Y BilimoriaLesly A DossettByron FalerAdil H HaiderMelina KibbeAshley M HolderJoseph D Phillips

strategic studieseducational leadershipethical leadershiporganization studiesadministrative leadershipmanagementleadership development

Systemic Therapy for Melanoma. Surgical Oncology Clinics of North America (2025)

melanomadermatologydermatological treatmentsystemic therapysystemic treatmentoncology

immune checkpoint blockadehigh social vulnerabilityinfectious diseasesdecreased richnessvulnerabilitygut microbiomedysbiosissarcoma patientsmicrobiome

Aso Author Reflections: Synoptic Reporting for Melanoma Nodal Surveillance Ultrasonography. Annals of Surgical Oncology (2024)

Kelsey B. MontgomeryAshley M. HolderKristy K. Broman

Aso Visual Abstract: Interdisciplinary Implementation of a Synoptic Reporting Template for Melanoma Nodal Surveillance Ultrasound. Annals of Surgical Oncology (2024)

Kelsey B. MontgomeryZoey N. DuncanAshley M. HolderConstantine M. BurganSamuel J. GalganoKristy K. Broman

interdisciplinary implementationsurgerysurgical oncologymelanomaultrasound

Defining Clinically Useful Biomarkers of Immune Checkpoint Inhibitors in Solid Tumours. Nature reviews. Cancer (2024)

Ashley M. HolderAikaterini DedeiliaKailan Sierra-DavidsonSonia CohenDavid LiuAparna ParikhGenevieve M. Boland

1
2
3
4
10 / page